Bottom line
"Beauty Blend" is a marketed name for GHK-Cu + KPV. Unlike many named blends, the sampled listings are unusually consistent in claiming 50 mg GHK-Cu and 20 mg KPV, but repeated vendor claims do not create a regulatory standard or independently verify vial contents. No published study of this exact mixture was identified.
No established or recommended human dose. The 50/20 amounts below are market observations, not guidance.
Name and formulation variability
| Observed source/date | Claimed components | Claimed amounts | Verification limits |
|---|---|---|---|
| Ameano Peptides (2026) | GHK-Cu, KPV | 50 / 20 mg | Vendor-declared; identity and contents not independently verified |
| Protide Health (2026) | GHK-Cu, KPV | 50 / 20 mg | Vendor-declared market observation |
| EZ Peptides (2026) | GHK-Cu, KPV | 50 / 20 mg | Vendor-declared market observation |
| Valor Peptides (2026) | GHK-Cu, KPV | 50 / 20 mg | Vendor-declared market observation |
Consistency across the sampled listings is descriptive only. It does not establish that all products called "Beauty Blend" use this composition or that any listed content was analytically confirmed.
Component evidence
Combination-specific studies
No published peer-reviewed study testing the exact GHK-Cu + KPV mixture was identified. Multiple vendor listings are not independent scientific replication.
Safety and interaction uncertainties
No combination-specific human safety, interaction, How a substance is absorbed, distributed, metabolized, and eliminated by the body; atlas pages report pharmacokinetic data such as half-life, metabolism, and clearance. Источник определения: Neutral gloss; usage context: Routes, devices, and absorption primer · Глоссарий, or toxicology data were identified.
GHK-Cu is a metal complex; total-mass labels do not by themselves resolve stoichiometry or free copper.
Identity, purity, sterility, and co-formulation stability cannot be inferred from repeated seller claims.
Regulatory and product-quality notes
"Beauty Blend" is not a regulatory or pharmacopoeial standard.
The cited pages are low-quality market observations and do not establish product quality or suitability for human use.
Apparent market convergence on 50/20 mg should not be mistaken for an approved formulation.
Evidence gaps
No combination-specific study
No independent cross-vendor analytical comparison
No published compatibility or stability study
No authoritative definition of the marketed name
Sources
Ameano Peptides. Beauty Blend market page. https://ameanopeptides.com/ accessed 2026-08-08.
Protide Health. Beauty Blend market page. https://protidehealth.com/ accessed 2026-08-08.
EZ Peptides. Beauty Blend market page. https://ezpeptides.com/ accessed 2026-08-08.
Valor Peptides. Beauty Blend market page. https://valorpeptides.com/ accessed 2026-08-08.